{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:26:11Z","timestamp":1762503971071},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1097\/inf.0000000000000222","type":"journal-article","created":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T08:16:55Z","timestamp":1388564215000},"page":"617-622","source":"Crossref","is-referenced-by-count":24,"title":["Virologic Response in Children Treated With Abacavir-compared With Stavudine-based Antiretroviral Treatment"],"prefix":"10.1097","volume":"33","author":[{"given":"Karl-G\u00fcnter","family":"Technau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Schomaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Kuhn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry","family":"Moultrie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashraf","family":"Coovadia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Eley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"Rabie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian","family":"Cox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa Salazar","family":"Vizcaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evans","family":"Muchiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary-Ann","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R6-16-20210202","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/QAD.0b013e3280e087e7","article-title":"Paediatric European Network for the Treatment of AIDS (PENTA). Lamivudineabacavir maintains virological superiority over zidovudinelamivudine and zidovudineabacavir beyond 5 years in children.","volume":"21","author":"Green","year":"2007","journal-title":"AIDS"},{"key":"R8-16-20210202","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/INF.0b013e31828c3738","article-title":"Poor early virologic performance and durability of abacavir-based first-line regimens for HIV-infected children.","volume":"32","author":"Technau","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R9-16-20210202","first-page":"730","article-title":"International Epidemiologic Databases to Evaluate AIDS Southern Africa (IeDEA-SA) Collaboration. Outcomes of the South African National Antiretroviral Treatment Programme for children: the IeDEA Southern Africa collaboration.","volume":"99","author":"Davies","year":"2009","journal-title":"S Afr Med J"},{"key":"R10-16-20210202","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/sim.4067","article-title":"Multiple imputation using chained equations: Issues and guidance for practice.","volume":"30","author":"White","year":"2011","journal-title":"Stat Med"},{"key":"R11-16-20210202","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/01621459.1996.10476908","article-title":"Multiple Imputation after 18 Years.","volume":"91","author":"Rubin","year":"1996","journal-title":"J Am Stat Assoc"},{"key":"R12-16-20210202","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1001\/jama.285.9.1155","article-title":"CNAAB3005 International Study Team. Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: a randomized equivalence trial.","volume":"285","author":"Staszewski","year":"2001","journal-title":"JAMA"},{"key":"R13-16-20210202","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/infdis\/jir505","article-title":"AIDS Clinical Trials Group Study A5202 Team. Abacavirlamivudine versus tenofovir DFemtricitabine as part of combination regimens for initial treatment of HIV: final results.","volume":"204","author":"Sax","year":"2011","journal-title":"J Infect Dis"},{"key":"R14-16-20210202","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1742-6405-6-3","article-title":"A randomized, controlled trial of initial anti-retroviral therapy with abacavirlamivudinezidovudine twice-daily compared to atazanavir once-daily with lamivudinezidovudine twice-daily in HIV-infected patients over 48 weeks (ESS100327, the ACTION Study).","volume":"6","author":"Kumar","year":"2009","journal-title":"AIDS Res Ther"},{"key":"R16-16-20210202","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMoa0800971","article-title":"CHER Study Team. Early antiretroviral therapy and mortality among HIV-infected infants.","volume":"359","author":"Violari","year":"2008","journal-title":"N Engl J Med"},{"key":"R18-16-20210202","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1128\/JCM.00431-12","article-title":"Early diagnosis of in utero and intrapartum HIV infection in infants prior to 6 weeks of age.","volume":"50","author":"Lilian","year":"2012","journal-title":"J Clin Microbiol"},{"key":"R19-16-20210202","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1097\/QAD.0b013e3281a3bec2","article-title":"High frequency of rapid immunological progression in African infants infected in the era of perinatal HIV prophylaxis.","volume":"21","author":"Mphatswe","year":"2007","journal-title":"AIDS"},{"key":"R20-16-20210202","doi-asserted-by":"crossref","first-page":"e1000430","DOI":"10.1371\/journal.pmed.1000430","article-title":"HIV-1 drug resistance emergence among breastfeeding infants born to HIV-infected mothers during a single-arm trial of triple-antiretroviral prophylaxis for prevention of mother-to-child transmission: a secondary analysis.","volume":"8","author":"Zeh","year":"2011","journal-title":"PLoS Med"},{"key":"R21-16-20210202","first-page":"156","article-title":"2011 update of the drug resistance mutations in HIV-1.","volume":"19","author":"Johnson","year":"2011","journal-title":"Top Antivir Med"},{"key":"R22-16-20210202","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1177\/135965350701200510","article-title":"Abacavir plasma pharmacokinetics in the absence and presence of atazanavirritonavir or lopinavirritonavir and vice versa in HIV-infected patients.","volume":"12","author":"Waters","year":"2007","journal-title":"Antivir Ther"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000000222","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T11:28:39Z","timestamp":1688902119000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201406000-00016"}},"subtitle":["A South African Multi-Cohort Analysis"],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000000222","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}